B Everaerdt - JoVE Visualize

Showing results (1-10 of 15) with videos related to

Pageof 2

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994

Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in miceB Everaerdt, P Brouckaert, W Fiers

European Journal of Immunology|April 1, 1992

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factorP Brouckaert, B Everaerdt, W Fiers

Lymphokine and Cytokine Research|August 1, 1992

Selective species specificity of tumor necrosis factor for toxicity in the mouseP Brouckaert, C Libert, B Everaerdt, et al.

Biochemical and Biophysical Research Communications|August 30, 1989

Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factorB Everaerdt, P Brouckaert, A Shaw, et al.

Reproduction (Cambridge, England)|July 29, 2005

Effects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte developmentD Nogueira, R Cortvrindt, B Everaerdt, et al.

Lymphokine Research|January 1, 1989

A role for interleukin 1 in the in vivo actions of tumor necrosis factorP G Brouckaert, C Libert, B Everaerdt, et al.

Agents and Actions|January 1, 1989

Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in miceP G Brouckaert, B Everaerdt, C Libert, et al.

Immunobiology|April 1, 1993

Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6P Brouckaert, C Libert, B Everaerdt, et al.

Immunity|September 12, 2000

Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthaseA Cauwels, W Van Molle, B Janssen, et al.

European Journal of Immunology|October 1, 1992

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine modelsC Libert, A Vink, P Coulie, et al.

Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:

Pageof 2

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994

Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in miceB Everaerdt, P Brouckaert, W Fiers

European Journal of Immunology|April 1, 1992

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factorP Brouckaert, B Everaerdt, W Fiers

Lymphokine and Cytokine Research|August 1, 1992

Selective species specificity of tumor necrosis factor for toxicity in the mouseP Brouckaert, C Libert, B Everaerdt, et al.

Biochemical and Biophysical Research Communications|August 30, 1989

Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factorB Everaerdt, P Brouckaert, A Shaw, et al.

Reproduction (Cambridge, England)|July 29, 2005

Effects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte developmentD Nogueira, R Cortvrindt, B Everaerdt, et al.

Lymphokine Research|January 1, 1989

A role for interleukin 1 in the in vivo actions of tumor necrosis factorP G Brouckaert, C Libert, B Everaerdt, et al.

Agents and Actions|January 1, 1989

Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in miceP G Brouckaert, B Everaerdt, C Libert, et al.

Immunobiology|April 1, 1993

Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6P Brouckaert, C Libert, B Everaerdt, et al.

Immunity|September 12, 2000

Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthaseA Cauwels, W Van Molle, B Janssen, et al.

European Journal of Immunology|October 1, 1992

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine modelsC Libert, A Vink, P Coulie, et al.

Pageof 2